ADA 2014 Report: National guidelines for lipids and blood pressure
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes,… read more.
New guidelines for Type 2 diabetes screening in children are less effective and more costly than previous screening methods.
In the largest study to date of the relationship between sleep apnoea and diabetes, a new study of more than 8,500 Canadian patients has demonstrated a link between… read more.
Pan-European Survey reveals low levels of asthma control in Ireland. Irish respondents are experiencing asthma symptoms nearly 3 days a week. 48% of Irish people with asthma are… read more.
Testing vitamin D alone is not enough – Combined assessment of parathyroid hormone along with vitamin D may be needed to assess the impact of vitamin D status… read more.
Testing vitamin D alone is not enough – Combined assessment of parathyroid hormone along with vitamin D may be needed to assess the impact of vitamin D status… read more.
From 2006 to 2008, nearly 75 per cent of patients with diabetes living in Ontario did not receive all of the tests recommended to properly monitor their disease…. read more.
by Bruce Sylvester – Colon cancer patients diagnosed before age 50 have more advanced stages of colon cancer at diagnosis but have better survival at all stages of… read more.
Significant survival benefit observed in women with HER2 negative breast cancer – ASCO Press Release.
Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO) – Press Release.
by Bruce Sylvester – Researchers report that a pooled analysis of two major trials suggests that short- and long-term outcomes of neoadjuvant chemotherapy followed by chemoradiotherapy in high-risk… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.